The randomized, double-blind, placebo-controlled study was published in Neurology on November 16, just two days after Eli Lilly announced its ... read more
Lasmiditan Delivers Migraine Relief After Two Hours Without High Cardiovascular Risk
Lasmiditan Delivers Migraine Relief After Two Hours Without High Cardiovascular Risk